The point is I've been scratching my head figuring out who Russell might try to solicit this product of ours to.
Based on current or past activity in HRV, the list is:
* GSK
* Gilead Sciences
* Boehringer Ingelheim
* Janssen Pharma (Johnson n Johnson)
Not a huge list but its not as if Biota is on its own...
players in the rhinovirus space, page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)